SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eledon reports updated Phase 2 Bestow extension study results

Eledon Pharmaceuticals presented updated long-term Phase 2 Bestow extension study results at the International Congress of the Transplantation Society.

ELDN